Storage & stability
Freeze-dried for a reason
There is a growing trade in BPC-157 and retatrutide sold as ready-to-use pens — already mixed into liquid, kept in someone's fridge, and shipped on. That convenience throws away the single thing that keeps a peptide intact: keeping it dry until the moment you use it. Here is why that matters, what proper storage actually involves, and what the evidence says about pre-mixed product.
This page explains, it does not instruct. It is educational background on pharmaceutical stability, not a how-to for handling, mixing or injecting anything. We give no doses and no protocols. Most peptides discussed here are not licensed medicines in the UK.
Why peptides are freeze-dried, not sold as liquid
Water is what wrecks a peptide. A peptide is a short, fragile chain of amino acids, and once it is floating in liquid, the water itself slowly chews through it and the chain falls apart. So the makers dry it into a tiny, stable powder — that is the white speck or flat cake you see in the bottom of a sealed vial. Dry, cold and in the dark, that powder keeps for a year or two.
You are only ever meant to add liquid to that powder right before you start using it. A pen that arrives already full of liquid has skipped the one step that keeps the peptide intact — and the clock has been running on it the whole time, in someone else's fridge, for who knows how long.
What happens to a peptide sitting in water
Drying is not fussiness. Once a peptide is dissolved, several chemical reactions start working on it at once, and they never stop — they only speed up or slow down with conditions.[1] The main ones:
Hydrolysis
Water molecules break the peptide backbone apart. The very solvent it is dissolved in is also its solvent for destruction. Strongly pH-dependent.
Deamidation
The most common pathway. Certain amino acids (asparagine especially) spontaneously rearrange, changing the molecule and usually inactivating it.
Oxidation
Oxygen and light attack vulnerable residues — methionine, cysteine, tryptophan, tyrosine — altering the structure.
Aggregation
Damaged or unfolded chains clump together. Aggregates are not just inactive; protein/peptide aggregates are linked to immune reactions.
Adsorption
Some of the peptide simply sticks to the glass or plastic of the container, quietly lowering the real dose — worst at low concentrations.
Every one of these is faster when it is warm, and several are faster in light.[1,5] A freeze-dried powder removes the water that drives most of them, which is why dry storage buys years and wet storage buys days to weeks.[3,13]
Bacteriostatic water, and why mixing is a point-of-use step
A lyophilised peptide has to be turned back into a liquid before it can be injected — “reconstituted”. In a clinical setting that is done with a specific diluent, and for anything entered more than once, that diluent is usually bacteriostatic water for injection: sterile water containing 0.9% benzyl alcohol as a preservative.[7] Plain sterile water for injection contains no preservative and is single-use only.[8]
The benzyl alcohol matters because a vial gets the needle put into it more than once. The preservative inhibits microbial growth between entries — but only for a limited window. The pharmacy standard for a punctured multi-dose vial is a 28-day beyond-use date, after which sterility can no longer be assumed.[10,11] Benzyl alcohol is also not harmless: it must never be used in newborns, where it has caused fatal “gasping syndrome”.[9]
Reconstitution is also physically gentle for a reason. The diluent is run slowly down the inside wall of the vial, and the peptide is left to dissolve or swirled — never shaken. Shaking whips air into the liquid, and the air–liquid interface is one of the most reliable ways to make a peptide unfold and aggregate.[6] The takeaway is not a recipe; it is that proper preparation is a controlled, just-before-use process. A pen that was mixed weeks or months ago, by an unknown hand, with an unknown diluent, has none of those controls.
Why it lives in the fridge — and why the freezer is not a fix once it's mixed
Temperature is the master dial on degradation. As a rule of thumb, reaction rates roughly double for every 10 °C rise (the Q10 rule), so a solution left at room temperature degrades far faster than one held at fridge temperature, 2–8 °C — the standard cold range for biologicals.[1,12] That is why a reconstituted peptide is refrigerated, and why lyophilised powder is kept colder still: typically −20 °C for the medium term and −80 °C for long-term storage.[12,13]
Heat
Speeds every degradation pathway. Time at a warm temperature is cumulative and does not reset by putting it back in the fridge.
Light
Drives photo-oxidation of aromatic residues. UV exposure of insulin caused cross-linking and a large drop in measured activity — the reason vials are amber and kept in their carton.
Freeze–thaw
Repeated freezing and thawing of a solution causes denaturation and aggregation through ice formation and concentration shifts. Solutions for long storage are aliquoted and frozen once — not frozen, thawed and refrozen.
The light point is not theoretical: under UV, insulin formed covalent dimers and lost a large fraction of its activity in hours.[5] And freezing is not a rescue for an already-mixed pen — repeated freeze–thaw cycles damage peptides in solution rather than preserving them.[12,13]
What the regulated pens actually require — and what reta and BPC-157 don't have
The licensed GLP-1 pens prove the point. They can be sold pre-filled only because the manufacturer ran validated stability studies, formulated and buffered the solution specifically to survive it, and printed hard limits on the label:
Ozempic (semaglutide)[14]
Refrigerate 2–8 °C. After first use, up to 56 days at room temperature (15–30 °C) or refrigerated. Do not freeze. Protect from light.
Wegovy (semaglutide)[15]
Refrigerate 2–8 °C. May be kept at 8–30 °C for up to 28 days before first use. Do not freeze. Keep in the carton to protect from light.
Mounjaro / Zepbound (tirzepatide)[16]
Refrigerate 2–8 °C. Up to 21 cumulative days at room temperature (≤30 °C). Do not freeze. Protect from light.
The contrast that matters
Retatrutide is an investigational triple GIP/GLP-1/glucagon receptor agonist still in clinical trials — it is not approved by the FDA, EMA or MHRA, and Eli Lilly states that anything sold outside its trials is illegal with no way to verify safety, purity or dosing.[17,18] There is therefore no manufacturer storage label and no validated stability data for any “reta” in a pen.
BPC-157 is likewise unapproved for human use anywhere, with scarce human data; the FDA placed it in a restricted category for compounding in 2023.[19] Every storage figure you see quoted for it comes from sellers, not from regulators or validated studies. A pre-mixed pen of either is operating with none of the safeguards the licensed pens above depend on.
The pre-filled pen problem, in the evidence
When researchers and regulators have actually tested grey-market product, the results line up with the chemistry above — and add contamination and dosing problems on top.
Wrong amount of active ingredient[20]
A 2024 peer-reviewed study test-purchased semaglutide from online sellers without a prescription and measured purity of just 7.7–14.4%, against the 99% claimed on the labels.
Contamination[20]
In that same study, bacterial endotoxin was found in every single sample tested — a direct marker of non-sterile manufacturing.
Dosing errors[21]
The FDA has logged well over a thousand adverse-event reports tied to compounded/unapproved GLP-1 products, including patients drawing 5 to 20 times the intended dose from multi-dose vials.
Counterfeits in the supply chain[22,23]
The FDA (2025) and WHO (Alert No. 2/2024) have both warned of falsified Ozempic, including counterfeit pens whose needle sterility could not be confirmed.
It is exactly what is being seized[24,25]
In October 2025 the UK MHRA raided an illicit Northampton factory and seized over 2,000 pre-filled pens of tirzepatide and retatrutide — reported as the largest single seizure of trafficked weight-loss medicines recorded. In 2025 the MHRA seized almost 20 million doses of illegally traded medicines.
Put together: a pre-filled “research” pen has skipped freeze-drying, has been in solution for an unknown time at an unknown temperature, carries no validated stability data, is not made to any quality standard, and — when tested — frequently contains the wrong amount of drug, contamination, or both. The MHRA's enforcement lead put it plainly: with medicines sourced outside a registered pharmacy, “there are no guarantees about what they contain.”[24]
The honest bottom line
- →Peptides are freeze-dried because water degrades them; dry storage buys years, solution buys days to weeks.
- →Reconstitution is meant to happen at the point of use, with the right diluent, gently, and the result kept cold, dark, and used within a short window.
- →A pre-mixed pen throws all of that away before it ever reaches you.
- →Retatrutide and BPC-157 have no approved product, so no validated storage or stability data exists for them at all — only sellers’ claims.
- →Where grey-market pens have been tested, they have shown wrong dosages, contamination and counterfeiting. They are precisely what regulators are now seizing.
None of this is a verdict on whether any peptide “works” — that is what the rest of the site grades. It is a narrower, more practical point: even on its own terms, a peptide that has been sitting in liquid in a stranger's fridge is unlikely to be what the label says it is. If you want to understand how we weigh the underlying evidence, start with how we grade.
Sources
Tagged by type: peer-reviewed studies and reviews, regulatory and pharmacopeial sources, manufacturer documentation, and reporting. Inline markers like [1] point here.
- 01Peer-reviewedDesigning Formulation Strategies for Enhanced Stability of Therapeutic Peptides in Aqueous Solutions: A Review — Nugrahadi PP, Hinrichs WLJ, Frijlink HW, Schöneich C, Avanti C, Pharmaceutics 15(3):935 (2023)
- 02Peer-reviewedEffect of Water on the Chemical Stability of Amorphous Pharmaceuticals: Deamidation of Peptides and Proteins, Journal of Pharmaceutical Sciences (2017)
- 03Peer-reviewedEffectiveness of Lyoprotectants in Protein Stabilization During Lyophilization, Pharmaceutics (PMC11510631) (2024)
- 04Peer-reviewedThe Effects of pH and Excipients on Exenatide Stability in Solution, Pharmaceutics 13(8):1263 (2021)
- 05Peer-reviewedUV-Light Exposure of Insulin: Pharmaceutical Implications upon Covalent Insulin Dityrosine Dimerization and Disulphide Bond Photolysis — Correia M, Neves-Petersen MT, Jeppesen PB, Gregersen S, Petersen SB, PLOS ONE 7(12):e50733 (2012)
- 06Peer-reviewedInterfacial stress in the development of biologics: surface-induced aggregation and particle formation, AAPS / J Pharm Sci (PMC6435788) (2019)
- 07RegulatoryBacteriostatic Water for Injection, USP — Prescribing Information — Hospira, Inc. (Pfizer), DailyMed, U.S. National Library of Medicine
- 08RegulatorySterile Water for Injection, USP — Prescribing Information — Hospira, Inc. (Pfizer), DailyMed, U.S. National Library of Medicine
- 09Peer-reviewedThe gasping syndrome and benzyl alcohol poisoning — Gershanik J, Boecler B, Ensley H, McCloskey S, George W, New England Journal of Medicine 307(22):1384–1388 (1982)
- 10RegulatoryGeneral Chapter <797> Pharmaceutical Compounding — Sterile Preparations (multi-dose beyond-use dating) — United States Pharmacopeia, USP–NF
- 11RegulatoryInjection Safety: Questions about Multi-dose Vials — Centers for Disease Control and Prevention, CDC
- 12ManufacturerHandling and Storage Guidelines for Peptides and Proteins — Sigma-Aldrich / Merck, Technical documentation
- 13
- 14RegulatoryOZEMPIC (semaglutide) injection — Prescribing Information — Novo Nordisk, DailyMed, U.S. National Library of Medicine
- 15
- 16ManufacturerHow should the Mounjaro (tirzepatide) KwikPen be stored? — Eli Lilly, Lilly Medical Information (UK)
- 17
- 18Peer-reviewedLY3437943, a novel triple GIP, GLP-1 and glucagon receptor agonist — Coskun T et al., Cell Metabolism (2022)
- 19Peer-reviewedRegeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing, Cureus / PMC12446177 (2025)
- 20Peer-reviewedMultifactor Quality and Safety Analysis of Semaglutide Products Sold by Online Sellers Without a Prescription, Journal of Medical Internet Research 26:e65440 (2024)
- 21RegulatoryFDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss — U.S. Food and Drug Administration, FDA
- 22RegulatoryFDA warns consumers not to use counterfeit Ozempic (semaglutide) found in U.S. drug supply chain — U.S. Food and Drug Administration, FDA Drug Alerts (2025)
- 23RegulatoryMedical Product Alert N°2/2024: Falsified OZEMPIC (semaglutide) — World Health Organization, WHO (2024)
- 24ReportingMHRA raids illegal weight-loss jab production line worth more than £250,000, The Pharmaceutical Journal (2025)
- 25ReportingWeight-loss drugs among £45m of illegally traded medicines seized in 2025, The Pharmaceutical Journal (2026)
Quantitative shelf-life windows for unlicensed peptides circulate widely on vendor pages; we have deliberately not repeated them as fact, because no validated stability data underpins them. The figures cited above for licensed products come from their regulatory labels.
Stay posted
Get the reality checks
We email when the evidence actually changes — new human trials, grade changes, safety signals. No spam, nothing for sale.
This page is educational and not medical advice. It does not tell you to obtain, possess, prepare or use any substance. Most peptides discussed on this site are not licensed medicines in the UK. Talk to a qualified clinician before any health decision.